Friday, June 3, 2011

Atala Discusses Human Organ, Tissue Engineering: Innovators - The Washington Post

Just sat in a talk by Donald Ingber. The Wyss Institute's accomplishments are mind-blowing.

6/3 TE-RegenMed-StemCell feed

     
    TE-RegenMed-StemCell feed    
   
Mesenchymal stem cells for treatment of CNS injury.
June 2, 2011 at 12:16 PM
 

Mesenchymal stem cells for treatment of CNS injury.

Curr Neuropharmacol. 2010 Dec;8(4):316-23

Authors: Azari MF, Mathias L, Ozturk E, Cram DS, Boyd RL, Petratos S

Brain and spinal cord injuries present significant therapeutic challenges. The treatments available for these conditions are largely ineffective, partly due to limitations in directly targeting the therapeutic agents to sites of pathology within the central nervous system (CNS). The use of stem cells to treat these conditions presents a novel therapeutic strategy. A variety of stem cell treatments have been examined in animal models of CNS trauma. Many of these studies have used stem cells as a cell-replacement strategy. These investigations have also highlighted the significant limitations of this approach. Another potential strategy for stem cell therapy utilises stem cells as a delivery mechanism for therapeutic molecules. This review surveys the literature relevant to the potential of mesenchymal stem cells for delivery of therapeutic agents in CNS trauma in humans.

PMID: 21629440 [PubMed - in process]

   
     
 
This email was sent to regenmd@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox
 
     

Thursday, June 2, 2011

Stem cell treatment to prevent leukemia returning is a step closer, say scientists

RegenMD - BioTime CEO Dr. Michael West to Present at the Jefferies 2011 Global ...

 
We just completed performing emergency maintenance on Feed My Inbox. All emails were delayed during this time. We appreciate your patience and are so sorry for any inconvenience this may have caused.
 
     
    RegenMD    
   
BioTime CEO Dr. Michael West to Present at the Jefferies 2011 Global ...
June 2, 2011 at 1:49 PM
 
He will discuss BioTime's business in regenerative medicine and provide an update on recent progress in developing its stem cell-based products. A link to the live webcast of the company's presentation will be available in the investors section of the ...
See all stories on this topic »
   
   
ASTM Standard characterizes hydrogels in regenerative medicine.
June 2, 2011 at 9:41 AM
 
Hydrogels are highly hydrated polymer networks that will play an increasingly important role in the realm of regenerative medicine over the next decade. The reason for the growth of hydrogels is twofold: A paradigm shift in tissue engineering toward ...
See all stories on this topic »
   
   
Case Western Reserve and Edheads: Using Clinical Trials to Advance Science ...
June 2, 2011 at 9:41 AM
 
"This is a great way to engage young people and help cultivate their interest in science while introducing them to stem cells," said Michael Gilkey, acting director for the National Center for Regenerative Medicine at Case Western Reserve School of ...
See all stories on this topic »
   
   
ASTM Standard characterizes hydrogels in regenerative medicine.
June 2, 2011 at 8:16 AM
 
The reason for the growth of hydrogels is twofold: A paradigm shift in tissue engineering toward using the body as a bioreactor to repair itself rather than cultivating tissue in vitro for implantation. A new ASTM standard will contribute to the study ...
See all stories on this topic »
   
   
How Do Cells Communicate with Each Other?
June 2, 2011 at 4:54 AM
 
The National Science Foundation's Advances in Biological Informatics program area has awarded a three-year, $1.12 million research grant to three Virginia Tech researchers with expertise in systems biology and tissue engineering: TM Murali of computer ...
See all stories on this topic »
   
   
The Candidate's Letters: What Thomas and Litvack Have to Say
June 2, 2011 at 2:33 AM
 
   
   
Prieto on Patent Reform
June 2, 2011 at 12:43 AM
 
   
   
CIRM Plans for Lobbyist to Push Patent Reform Position
June 1, 2011 at 5:28 PM
 
   
   
Embyronic Stem Cells: The Evolution of Informed Consent
June 1, 2011 at 5:14 PM
 
by Kim Faulkner On May 4, 2011, the California Institute for Regenerative Medicine (CIRM) awarded $25-million to Geron Corp. to support the first ever FDA approved clinical trial based on cells derived from human embryonic stem cells. ...
See all stories on this topic »
   
   
hESC Patents Piece from San Diego Researchers
June 1, 2011 at 3:52 PM
 
   
   
Get used to Bartolo Colon-style stem cell procedures, because they're going to ...
June 1, 2011 at 3:50 PM
 
In the next five years the field of regenerative medicine, using your own body cells to heal itself is going to explode. I mean athletes are really going to be demanding these types of things. Instead of major surgeries they're going to want to use ...
See all stories on this topic »
   
   
Biomedical facility shows best of modern lab design
June 1, 2011 at 2:24 PM
 
By Julie S. Higginbotham Univ. of Southern California, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, Los Angeles. Five stories plus a basement; 91485 ft 2 ; $65 million. The building was funded in part by a ...
See all stories on this topic »

R & D Magazine
   
   
"Good Ethics Makes for Good Science"
June 1, 2011 at 2:24 PM
 
That doesn't fit the media template of embryonic stem cells being the "gold standard" for regenerative medicine, and indeed, the "only hope" for people struggling against diseases such as diabetes and Parkinson's. Hence, advances that would have ...
See all stories on this topic »

First Things (blog)
   
     
 
This email was sent to agupta1213+termsc@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox